1. MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
   Hong Shik Yun et al, 2024, Scientific Reports CrossRef
2. The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents
   Maher Kurdi et al, 2021, Pathology and Oncology Research CrossRef
3. Prognostic and Predictive Biomarkers in Gliomas
   Paulina Śledzińska et al, 2021, International Journal of Molecular Sciences CrossRef
4. The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
   Arne Christians et al, 2019, Acta Neuropathologica Communications CrossRef
5. MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines
   Alessio Malacrida et al, 2022, Biology CrossRef
6. MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
   Mateusz Szylberg et al, 2022, Biomedicines CrossRef